Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex

BACKGROUND: Tamoxifen is currently used for the treatment of both early and advanced estrogen receptor (ER) positive breast cancer in pre- and post-menopausal women. However, using tamoxifen routinely to inhibit endogenous or exogenous estrogen effects is occasionally difficult because of its potent...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Nanobiotechnology
Huvudupphovsmän: Lin, Yu-Ling, Chen, Chia-Hung, Wu, Hsin-Yi, Tsai, Nu-Man, Jian, Ting-Yan, Chang, Yuan-Ching, Lin, Chi-Hsin, Wu, Chih-Hsiung, Hsu, Fei-Ting, Leung, Ting Kai, Liao, Kuang-Wen
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2016
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4759757/
https://ncbi.nlm.nih.gov/pubmed/26892504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-016-0163-3
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk